isoenzymes, which may increase the rate of biotransformaEffect of Coexposure to Methyl Ethyl Ketone (MEK) on n-tion of a solvent metabolized by such isoenzymes during Hexane Toxicokinetics in Human Volunteers. van Engelen, coexposure. Thus, Tardif et al. (1994) mans as a result of enzyme induction by ethanol. It was reported that the biotransformation of benzene to phenolic
, but it should be noted that these studies considered short-term exposure.
In this study, we have investigated the toxicokinetic interaction between MEK and n-hexane by exposing volunteers for 15.5 min (acute exposure). Kinetic evaluation of the concentration-time courses of n-hexane in exhaled alveolar air and of 2,5-hexanedione in serum after exposure to nhexane alone and after coexposure with MEK were carried out to answer the following questions: (1) Is there an effect of MEK on the toxicokinetics of n-hexane or 2,5-hexanedione during and after short-term exposure to concentrations around threshold limit value (TLV) concentrations? (2) Which predictions can be made of the consequences of combined exposure to these two solvents in occupational prac- groups used in this study. In the morning (AM) volunteers were exposed for 15.5 min to n-hexane or a combination of n-hexane and MEK. In the afternoon (PM), approximately 4 hr later, volunteers were exposed again
MATERIALS AND METHODS
to n-hexane or to a mixture of n-hexane and MEK. The exposure concentrations of MEK are shown in Fig. 1 ; the concentrations of n-hexane for each Chemicals individual are presented in Table 1 .
n-Hexane (pro analysis, 99%), methyl ethyl ketone, (pro analysis, 99.5%) (Merck, Darmstadt, Germany), cyclohexane, 2,5-hexanedione (Aldrich Chemie, Steinheim, Germany), 2,4-pentanedione, and pentafluorobenzylVenous blood was obtained via a cannula (Venflon 2, 1.4 mm o.d., 17G; hydroxylamine (PFBHA) (Sigma Chemical Co., St. Louis, MO) were used.
Viggo-Spectramed, Sweden) inserted into a cubital vein. To prevent blood clotting, the cannula was flushed continuously with saline using a pump Subjects and Exposures (Infusa T, Medis, Milano, Italy) set at a low flow (5 ml/hr); after each blood sampling the cannula was flushed with 10 ml saline. The healthy volunteers (16 males, 3 females) were between 19 and 26 years old. They were not allowed to take alcoholic beverages for 24 hr Alveolar Air and Blood Sampling before the start of the experiments; none of them used any pharmaceutical drugs. All subjects gave their informed consent. This study was approved During and after exposure, the last part of the alveolar air was sampled by the Medical Ethics Committee of the University of Amsterdam and the after a breath-holding time of 30 sec; according to procedures described principles of the Declaration of Helsinki (1964) were followed.
earlier (Opdam and Smolders, 1986) , it can be calculated that at that time The inhalation exposure procedure has been described by Opdam and the concentration in the alveolar air (ÅC alv,eq ) is close to equilibrium with Smolders (1986) . Briefly, volunteers were in a sitting position and inhaled the concentration in mixed venous blood (C ven ). Apart from small systematic via a one-way valve, connected to a Tedlar (DuPont, DE) bag. This bag errors, it can be assumed that the concentration-time course of n-hexane was filled with medical air, and to achieve the desired concentration of in alveolar air reflects the concentration-time course of n-hexane in the solvent vapor, solvent was introduced, at least 16 hr before the start of mixed venous blood. Therefore, for further data analysis we assumed that exposure, using a Hamilton syringe. During exposure the total amount of (after 30 sec of breath-holding) C alv,eq Å C ven /l, where l Å blood/air partition exhaled air was collected in another Tedlar bag. To determine the concentra-coefficient of n-hexane. To study the fast kinetics and to describe accurately tion in the bags containing the inhaled and exhaled air (C I and C e , respec-the shape of the concentration-time course, frequent sampling is necessary. tively), 1-ml air samples were withdrawn and analyzed. In addition, alveolar During exposure and the first 30 min following it, samples were collected air was sampled and collected in a prewarmed 70-ml glass tube. This glass every 3-5 min. From 45 until 90 min after the start of exposure, alveolar tube had two screw caps with rubber septa covered with a layer of Teflon air and blood were sampled every 10 min; after this time an interval of 20 (PFTE) to prevent absorption into the silicon rubber. Preceding coexposure min was used. A detailed description of the toxicokinetic analysis of the to the n-hexane and MEK mixture, volunteers were exposed to 200 or 300 data is presented in the Appendix. ppm MEK for 10 min. Because it was anticipated that the rise in 2,5-hexanedione in plasma might become important in the data analysis, the Chemical Analysis volunteers were preloaded with MEK; under those conditions the effect of MEK might be more easily measurable. Subsequently, the volunteers inAnalysis of n-hexane. Alveolar air was sampled after 30 sec of breathholding, during and after exposure, and collected in a 70-ml glass tube. haled the mixture of n-hexane (approximately 2.4 mM) and MEK (200 or 300 ppm; 8.2 or 12.3 mM, respectively) for 15.5 min. On the same day, 4 Samples (1 ml) were drawn from the bags that contained the inhaled and exhaled air using a gas-tight 1-ml Hamilton syringe and were injected in a hr preceding or 4 hr after the combined exposure, a reference experiment was carried out, in which the volunteers were exposed to n-hexane (approxi-70-ml glass tube. All tubes were analyzed for n-hexane using a purge and trap injection system (Chrompack, Middelburg, The Netherlands) coupled mately 2.4 mM) as a single solvent (Fig. 1, group 2, 3, or 4) . To evaluate differences in kinetics between morning and afternoon exposure, data ob-to a gas chromatograph (Hewlett Packard Model 5890 A) equipped with a flame ionization detector. Through both caps of the tube a needle was tained from volunteers exposed to n-hexane alone both in the morning and in the afternoon were used as a control (group 1). inserted, and a N 2 -flow (40 ml/min) purged the contents of the tube for 4 min onto the cold trap (0100ЊC). Subsequently, the trap was heated to During exposure, the concentrations of n-hexane in inhaled and exhaled air were determined, as well as the breathing minute volumes and frequency. 250ЊC in a few seconds and the contents were injected. n-Hexane calibration curves were prepared using a gas standard generator (Model 350, Analytical For each individual, these values are presented in Table 1 . Note. For each individual, n-hexane concentrations (concentration inhaled, C I ; and concentration exhaled, C e ), breathing minute volume (MV), and breathing frequency ( f ) are reported. Instrument Development Inc., Avondale, PA) with capillary diffusion tubes at constant temperature. Subsequently, n-hexane was diluted to the approToxicokinetic Parameters of n-Hexane, Presented as a Ratio: priate concentrations with air, collected in a 70-ml glass tube, and analyzed. Coexposure to n-Hexane / MEK Relative to Exposure to n-Hexane GC conditions. In order to separate the MEK peak from the n-hexane Alone peak, two capillary columns were used, connected by a glass connector. The first was a cross-linked methyl siloxane column (HP1, Hewlett Packard) A1 A2 V a 25 m 1 0.2 mm, film thickness 0.11 mm. The second column was a WCOT fused silica (CPsil43CB, Chrompack, Middelburg, The Netherlands). The Group 1; n Å 5 head pressure used was 85 kPa. After injection by the purge and trap system, AM: n-hexane 1.00 (0.04) 1.01 (0.18) 0.92 (0.07) the oven temperature was 35ЊC and was increased after 4.5 min at a rate PM: n-hexane of 70ЊC/min to 100ЊC. The retention times were 3.9 and 4.4 min for n-Group 2; n Å 5 hexane and MEK, respectively. AM: n-hexane 0.98 (0.05) 1.07 (0.16) 1.05 (0.15) Determination of 2,5-hexanedione. Serum was analyzed for 2,5-hex-PM: n-hexane / 200 ppm anedione according to Kežić and Monster (1991) , with the following slight MEK modification (Van Engelen et al., 1995a) . A 100-ml sample of 0.33 M sodium Group 3; n Å 4 citrate buffer, pH 2.2, was mixed with 400 ml serum. As internal standard, AM: n-hexane 1.00 (0.01) 1.01 (0.06) 1.00 (0.09) 50 ml of a 4.9 mM solution of 2,4-pentanedione was added, as well as 50 PM: n-hexane / 300 ppm ml of a 20 mg/ml aqueous solution of the derivatization agent O- (2, 3, 4, 5, hydroxylamine (PFBHA). Standard samples were pre-Group 4; n Å 4 pared by adding 0-200 ml of 3.3 mM aqueous solution of 2,5-hexanedione AM: n-hexane / 300 ppm to blank serum samples from the same volunteer. The reaction was allowed MEK 1.00 (0.05) 1.02 (0.11) 1.03 (0.14) to proceed for at least 16 hr at room temperature; 300 ml cyclohexane was PM: n-hexane added and samples were left rotating for 90 min. The samples were centrifuged for 10 min (Eppendorf centrifuge, 3000g) and 1 ml of the cyclohexane Note. Areas A1 (during exposure) and A2 (after exposure) were normalextract was injected onto the GC column.
ized to functional intake. V a , functional alveolar ventilation rate. Values given are mean ratios of n volunteers; standard deviations are shown in parentheses. For group 1 (exposure to n-hexane as single solvent in the RESULTS morning (AM) and in the afternoon (PM)) the ratio was expressed as AM value relative to the PM value. Due to an experimental error no information
A. Toxicokinetics of n-Hexane in Exhaled Air
on the concentration of n-hexane in alveolar air is available for one volunteer (m18, group 3). As a result the parameters A1, A2, and V a could be calcu-
The time course of the n-hexane concentration in exhaled lated only for n Å 4. alveolar air was determined after alveolar air sampling with a breath-holding time of 30 sec. Under these conditions, the alveolar concentration is considered to be in equilibrium morning (AM) influences the afternoon exposure to n-hexwith the mixed venous blood entering the lungs (C ven ) (see ane alone. the Appendix). Several parameters for the kinetics of nCoexposure to MEK did not significantly alter the kinetic hexane have been determined: the area under the n-hexane parameters for n-hexane (Table 2) . concentration-time curve during and after exposure (A1 and A2, respectively) and the functional alveolar ventilation rate B. Toxicokinetics of 2,5-Hexanedione in Blood (V a ) (for calculation of these parameters see the Appendix). A1 and A2 were normalized to functional intake (C I V a t 1 ) During and after exposure, blood was sampled and the serum was analyzed for the concentration of 2,5-hexanedi- (Opdam, 1989) .
Exposure to n-hexane alone, both in the morning (AM) one. Contrary to the lack of effect of MEK on the kinetic parameters of n-hexane, the formation of 2,5-hexanedione and in the afternoon (PM), served as a control experiment. Little variation in the toxicokinetics of n-hexane (and 2,5-was severely affected: the concentration-time course of 2,5-hexanedione after coexposure to 300 ppm MEK was differhexanedione) between the morning and the afternoon exposures within the same subject was observed, as is confirmed ent from that obtained after exposure to n-hexane alone.
Coexposure to the lower concentration of MEK (200 ppm), by the results of group 1 (Table 2) .
To assess the effect of MEK on the toxicokinetics of however, had no effect (Table 3) . A typical example of the concentration-time course of n-hexane, the ratio for each parameter was expressed as coexposure relative to single solvent exposure.
2,5-hexanedione, measured in serum obtained from a volunteer exposed for 15.5 min to n-hexane alone both in the In the first set of coexposure experiments, volunteers were exposed to 200 ppm MEK in the afternoon (group 2). There morning (at t Å 0) and 4 hr later, in the afternoon (group 1), is shown in Fig. 2a . These two time courses look very was very little, if any, effect of MEK on the concentrationtime courses of n-hexane and 2,5-hexanedione. Therefore, similar. Figure 2b presents a typical concentration-time course of 2,5-hexanedione after exposure to n-hexane alone the MEK concentration was increased to 300 ppm (group 3). The order of coexposure and exposure to n-hexane alone in the morning and to a mixture of n-hexane and MEK in the afternoon (group 3). There is a marked difference bewas also changed to examine whether coexposure in the Note. Slopes are expressed as a ratio (coexposure relative to slope after exposure to n-hexane alone). For group 1 (exposure to n-hexane as single solvent in the morning (AM) and in the afternoon (PM)) the ratio was expressed as AM value relative to the PM value.
* Significantly different from control (p õ 0.001) (Student's t test). ** Significantly different from control (p õ 0.05) (Student's t test).
tween the curves obtained following mixed exposure and the morning (AM) and the afternoon (PM) exposures (Fig.  4) . As the duration of the exposure was 15 min, the maxiexposure to n-hexane alone; the peak concentration was lower and the time required to reach this peak increased. mum concentration is reached 1 to 4 min after cessation of the exposure. This is shown in more detail in Fig. 3 .
To characterize the shape of the first part of the curve Two groups of volunteers were exposed to a combination of n-hexane and MEK in the afternoon: one group quantitatively, two parameters were determined: its slope and T max . The first parameter, slope, was calculated by linear was exposed to a MEK concentration of 200 ppm (group 2), the other to a concentration of 300 ppm (group 3). regression analysis of the concentration-time course during exposure; it indicates the rate at which 2,5-hexanedione ap-The individual exposure concentrations of n-hexane are presented in Table 1 . In group 2 no decrease in slope due pears in the blood (mM/hr). The second parameter, T max , is the time required for 2,5-hexanedione to reach a maximum to the combined exposure could be observed; the mean ratio of slopes was 0.99. In this group, there is a trend to serum concentration value. The two parameters are visually explained in Fig. 3 . The slopes are presented in Table 3 higher values of T max on mixed exposure compared to that seen with single n-hexane exposure (24.4 versus 20.4 again as a ratio (slope after coexposure relative to slope after exposure to n-hexane alone). Ratios of T max are presented in min). The effect of MEK coexposure on the slope is evident, however, in group 3, where volunteers were exposed Fig. 4 . Subjects that were exposed to n-hexane as a single solvent during both the first and the second exposures (group to an MEK concentration of 300 ppm in the afternoon.
The slope in the case of mixed exposure was about three-1) have values for the ratio of the slopes that are close to unity: the mean value of the ratio (first exposure (AM) rela-fold lower than obtained on exposure to n-hexane alone: a mean value of 0.35. The effect on T max was also more tive to the second exposure (PM)) is 1.03 (Table 3) (AM) to 31.6 min after combined exposure (PM). In an-Kinetic Modeling other set of experiments, volunteers were first exposed Kinetic modeling may be useful to simulate the effect of (AM) to n-hexane and MEK (300 ppm) and 4 hr later a second compound on the time course of 2,5-hexanedione. (PM) to n-hexane alone (group 4). The effects of MEK The entire kinetic process from n-hexane intake during expocoexposure on the slope are again evident: the ratios have sure, via the n-hexane blood concentration, the formation a mean value of 0.46. T max also seemed to increase as and concentration of intermediate metabolite(s) (M), the forcompared to the control situation, although less than in mation of 2,5-hexanedione, and finally the 2,5-hexanedione group 3; this increase is not statistically significant (Table  3 ; Fig. 4) .
blood concentration can be considered as a cascade of con-MEK has a pronounced, dose-dependent effect on the rate with which 2,5-hexanedione appears in the blood: coexposure to 300 ppm MEK caused a decrease in slope, whereas exposure to 200 ppm MEK caused no change compared with the control value; T max , however, appeared to increase also after coexposure to only 200 ppm MEK. Coexposure to 300 ppm MEK in the first (AM) or second (PM) period (groups 3 and 4) had the same effect: for both groups, slopes decreased to a similar extent, compared with exposure to nhexane alone. The effect of coexposure on T max was, however, less pronounced in group 4 than in group 3. Since we cannot exactly define at which step MEK and n-hexane interact we cannot explain this dose-dependency of MEK; it may be due to a metabolite of n-hexane, formation of which, to the required level for interaction, may be strongly dose-dependent. ane and MEK. For instance, a biotransformation pathway leading to nonneurotoxic metabolites of n-hexane could have been inhibited, thereby increasing the concentration of 2,5-nected kinetic systems (Opdam, 1991) . Inhibition of the con-hexanedione. However, animal studies had already sugversion of the intermediate metabolite to 2,5-hexanedione gested that after short-term coexposure to MEK and n-hexcan be simulated by lowering the metabolic clearance of M. ane the concentration of 2,5-hexanedione in blood was deAs a result, the half-time of M increases and the rate of creased in comparison with exposure to n-hexane alone: rats formation of 2,5-hexanedione (i.e., clearance 1 blood con-exposed for 8 hr to the very high level of 2000 ppm ncentration of M) becomes relatively low. In Fig. 5 , inhibition hexane alone or in combination with 2000 ppm MEK were by MEK is simulated by a fourfold lowering of the metabolic studied by Shibata et al. (1990) . If exposed to n-hexane clearance of M. As a result, the slope of 2,5-hexanedione alone, 2,5-hexanedione in serum increased until 2 hr after decreases and T max increases.
termination of exposure to a peak concentration of 143 mM. After coexposure, however, the peak concentration of 2,5-
DISCUSSION
hexanedione was only 18.6 mM, which was reached 8 hr
The present volunteer study reveals an effect of MEK coexposure on n-hexane biotransformation, after short-term (15.5 min) exposure to relatively low concentrations. The fast kinetics of n-hexane and 2,5-hexanedione could be accurately studied, as blood and alveolar air were sampled frequently. In addition, sensitive analytical procedures were applied, so that small changes in concentration could be identified. To the best of our knowledge, the effects of MEK on the kinetics of n-hexane have not been studied in a laboratory setting using volunteers before.
Very little, if any, effect of coexposure to MEK was observed on the toxicokinetic parameters of n-hexane itself (Table 3) . It is evident, however, that there is an effect of MEK on the rate of metabolism of n-hexane to 2,5-hexanedione. If the volunteers are exposed only to n-hexane, there is only a small variation between the 2,5-hexanedione con- the control value and seems to be cut off.
FIG. 5.
Simulation of the concentration-time course of 2,5-hexanedione after coexposure to n-hexane and MEK (rrr) or after exposure to n-hexane alone (-). after termination of exposure. As the levels of exposure are of these steps: given the structural similarity between MEK extremely high compared to the occupational situation, these (2-butanone) and 2-hexanone, it is plausible that MEK comresults could not be simply extrapolated to the volunteer petes with 2-hexanone for the substrate binding site of the setting (dose-dose extrapolation and species-species ex-various enzymes involved in these steps. The decrease in trapolation). Yet, in the present study, using low concentra-slope and the prolongation of formation of 2,5-hexanedione tions, the same effect was observed, confirming its relevance in combination with the apparently unchanged n-hexane for the occupational setting.
elimination, suggests an accumulation of an intermediate n-Hexane metabolism to 2,5-hexanedione requires several precursor of 2,5-hexanedione. After cessation of exposure, intermediate steps (Fig. 6 ). MEK could possibly inhibit each this accumulated metabolite will then be slowly converted to 2,5-hexanedione. The kinetic simulation (Fig. 5) gives support to the suggestion that the changes observed during the time course of 2,5-hexanedione may be caused by an inhibition of the metabolic conversion of an intermediate metabolite to 2,5-hexanedione. There is no need to postulate either any effect on the time course of n-hexane itself or any changes in the elimination kinetics of 2,5-hexanedione metabolism after its formation. Nevertheless, the tentative model described does not exclude other alterations in the kinetics of the drug metabolism process from n-hexane intake to 2,5-hexanedione formation. Shibata et al. (1990) reported a decrease in the concentration of 2-hexanone in serum following high-dose coexposure in the rat. The toxicokinetics of this metabolite were changed, however, as the half-life of 2-hexanone in the coexposure group was twice as long as that in the n-hexane alone group.
In the present study, we were not able to detect 2-hexanone in the serum of volunteers, possibly due to a lack of sensitivity of our analytical method. The concentrations of n-hexane and MEK to which the volunteers were exposed were very low in comparison with the rat studies of Shibata et al. (1990) . Thus, it remains to be seen whether the mechanism at high doses in the rat may be extrapolated to that at low doses in man. Recent studies in the rat in our laboratory using exposure levels similar to those given to our volunteers confirmed that the effects observed in the volunteers are very similar to those observed in rats (both using the same concentration levels and exposure-duration times) (Van Engelen, 1995b; Van Engelen et al., in preparation) .
An interaction during short-term coexposure to n-hexane and MEK can be very different from that produced upon chronic coexposure (Shibata et al., 1990) . Thus, Robertson et al. (1989) found elevated levels of 2,5-hexanedione (approx. eightfold) in blood of rats after 4 days of pretreatment with MEK (1.87 ml/kg/day, by gavage), followed by a single inhalation exposure to n-hexane (1000 ppm). After these 4 FIG. 7. Schematic overview of the toxicokinetics of gas exchange in the lungs. The lungs are represented as an alveolar air and a pulmonary days of MEK administration, the activity of 7-ethoxycoumablood compartment. Net uptake is the difference in concentration between rin-O-deethylase was increased by up to 500%, most probathe inhaled and exhaled air (C 1 and C e , respectively), multiplied by the bly due to enzyme induction. Obviously, during short-term minute volume (MV). The rate of functional intake (RFI) is equal to V a C I . coexposure (15 min to a low concentration in our experiments), MEK will not induce the biotransformation enzymes involved in n-hexane metabolism. However, it may inhibit During exposure, n-hexane (inhaled concentration C I ) can the biotransformation from n-hexane to 2,5-hexanedione. be transported to the pulmonary blood with a rate equal to If during chronic coexposure to MEK and n-hexane inducthe functional alveolar ventilation rate V a . This rate repretion of biotransformation enzymes by MEK plays a role, sents the functional alveolar volume per minute that is in then the design of the volunteer experiments reported here equilibrium with the arterial blood leaving the lungs. This cannot be used to predict the effects produced in occupavolume is smaller than the minute breathing volume, as it tional settings in which workers may be exposed to the mixonly takes into consideration that part of the lungs which is ture chronically. The direct interaction between the two solable to exchange with blood (''functional volume'') and does vents as discussed above, will also occur during chronic not include the anatomical and functionally dead volume. nexposure at occupationally relevant concentrations, in addiHexane is also eliminated by the blood to the lungs, with a tion to eventual inducting effects of MEK. It seems likely rate of V a , with a concentration of C art /l. In the case of nthat the mechanisms of interaction are similar to those ochexane, l has a value of 0.8. The term, V a 1 C art /l, is equal curring in rats. In humans, the potentiation of neurotoxicity to the product of the pulmonary clearance and the concentraby MEK is most probably not caused by inhibition of one tion in mixed venous blood: Cl pul 1 C ven (see below). of the pathways leading to nontoxic metabolites of nIn blood, the amount of n-hexane leaving the lung is equal hexane, but rather by enzyme induction to form more 2,5-to the concentration in arterial blood (C art ) multiplied by the hexanedione.
cardiac output Q; the amount of n-hexane in the returning mixed venous blood is equal to the concentration in mixed APPENDIX: TOXICOKINETIC ANALYSIS OF n-HEXANE venous blood, C ven , multiplied by Q. During exposure, C ven
IN ALVEOLAR AIR
is lower than C art , due to distribution and metabolic processes in the body. All processes presented in Fig. 7 can be described using During normal breathing, during and after exposure, ntwo equations: hexane is transported through the lungs to the blood as is For the alveolar air compartment, presented schematically in Fig. 7 . n-Hexane is exchanged between the alveolar air and the (pulmonary) blood compart-MV(C I 0 C e ) Å V a (C I 0 C art /l).
(1) ment.
The volunteer inhales air with a n-hexane concentration of For the pulmonary blood compartment, C I and exhales air with a concentration of C e . The difference between C I and C e multiplied by the breathing minute volume (MV) and the duration of exposure (t 1 ) results in the C I V a / QC ven Å C art V a / QC art .
(2) amount that remained in the body (net uptake). This amount is equal to the amount taken up by the blood compartment
The rate of elimination from the blood to the alveolar compartment is considered to be a continuous process both minus the amount eliminated from the blood into the lungs.
